• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期非小细胞肺癌复发预测。

On Predicting Recurrence in Early Stage Non-small Cell Lung Cancer.

机构信息

Data Science Institute, NUI Galway, Galway, Ireland.

Insight Centre for Data Analytics, NUI Galway, Galway, Ireland.

出版信息

AMIA Annu Symp Proc. 2022 Feb 21;2021:853-862. eCollection 2021.

PMID:35308971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8861763/
Abstract

Early detection and mitigation of disease recurrence in non-small cell lung cancer (NSCLC) patients is a nontrivial problem that is typically addressed either by rather generic follow-up screening guidelines, self-reporting, simple nomograms, or by models that predict relapse risk in individual patients using statistical analysis of retrospective data. We posit that machine learning models trained on patient data can provide an alternative approach that allows for more efficient development of many complementary models at once, superior accuracy, less dependency on the data collection protocols and increased support for explainability of the predictions. In this preliminary study, we describe an experimental suite of various machine learning models applied on a patient cohort of 2442 early stage NSCLC patients. We discuss the promising results achieved, as well as the lessons we learned while developing this baseline for further, more advanced studies in this area.

摘要

早期发现和减轻非小细胞肺癌(NSCLC)患者的疾病复发是一个重要问题,通常通过通用的随访筛查指南、自我报告、简单的列线图或使用回顾性数据分析来预测个体患者复发风险的统计模型来解决。我们假设,基于患者数据训练的机器学习模型可以提供一种替代方法,能够同时更有效地开发许多互补的模型,具有更高的准确性,对数据收集协议的依赖性更低,并提高预测的可解释性。在这项初步研究中,我们描述了一套应用于 2442 例早期 NSCLC 患者队列的各种机器学习模型的实验套件。我们讨论了所取得的有希望的结果,以及在开发该基线以进行该领域更先进的研究时所吸取的经验教训。

相似文献

1
On Predicting Recurrence in Early Stage Non-small Cell Lung Cancer.早期非小细胞肺癌复发预测。
AMIA Annu Symp Proc. 2022 Feb 21;2021:853-862. eCollection 2021.
2
Development and Validation of Web-Based Nomograms to Precisely Predict Conditional Risk of Site-Specific Recurrence for Patients With Completely Resected Non-small Cell Lung Cancer: A Multiinstitutional Study.基于网络的Nomograms 模型的建立与验证:用于精准预测完全切除的非小细胞肺癌患者的特定部位复发的条件风险:一项多机构研究。
Chest. 2018 Sep;154(3):501-511. doi: 10.1016/j.chest.2018.04.040. Epub 2018 Jun 18.
3
A comparison of machine learning methods for predicting recurrence and death after curative-intent radiotherapy for non-small cell lung cancer: Development and validation of multivariable clinical prediction models.机器学习方法预测非小细胞肺癌根治性放疗后复发和死亡的比较:多变量临床预测模型的建立和验证。
EBioMedicine. 2022 Mar;77:103911. doi: 10.1016/j.ebiom.2022.103911. Epub 2022 Mar 3.
4
Machine Learning-Assisted Recurrence Prediction for Patients With Early-Stage Non-Small-Cell Lung Cancer.机器学习辅助早期非小细胞肺癌患者的复发预测。
JCO Clin Cancer Inform. 2023 Jul;7:e2200062. doi: 10.1200/CCI.22.00062.
5
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab.用于预测接受纳武利尤单抗治疗的非小细胞肺癌患者生存情况的列线图。
J Transl Med. 2019 Mar 27;17(1):99. doi: 10.1186/s12967-019-1847-x.
6
Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy.肺癌根治术后 IA 和 IB 期患者总生存和无复发生存的预测列线图
Clin Lung Cancer. 2021 Jul;22(4):e574-e583. doi: 10.1016/j.cllc.2020.10.009. Epub 2020 Oct 22.
7
A nomogram to predict brain metastasis as the first relapse in curatively resected non-small cell lung cancer patients.用于预测根治性切除的非小细胞肺癌患者首次复发为脑转移的列线图。
Lung Cancer. 2015 May;88(2):201-7. doi: 10.1016/j.lungcan.2015.02.006. Epub 2015 Feb 16.
8
Nomograms for predicting progression and efficacy of post-operation radiotherapy in IIIA-pN2 non-small cell lung cancer patients.预测IIIA-pN2期非小细胞肺癌患者术后放疗进展和疗效的列线图。
Oncotarget. 2017 Jun 6;8(23):37208-37216. doi: 10.18632/oncotarget.16564.
9
Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.列线图预测手术切除的 I 期非小细胞肺癌患者的特定原因死亡率:竞争风险分析。
Clin Lung Cancer. 2018 Mar;19(2):e195-e203. doi: 10.1016/j.cllc.2017.10.016. Epub 2017 Oct 28.
10
Synergy between imputed genetic pathway and clinical information for predicting recurrence in early stage non-small cell lung cancer.基于遗传途径信息与临床资料的综合分析预测早期非小细胞肺癌的复发。
J Biomed Inform. 2023 Aug;144:104424. doi: 10.1016/j.jbi.2023.104424. Epub 2023 Jun 21.

引用本文的文献

1
Opportunities and challenges in lung cancer care in the era of large language models and vision language models.大语言模型和视觉语言模型时代肺癌护理中的机遇与挑战
Transl Lung Cancer Res. 2025 May 30;14(5):1830-1847. doi: 10.21037/tlcr-24-801. Epub 2025 May 23.
2
Decoding Recurrence in Early-Stage and Locoregionally Advanced Non-Small Cell Lung Cancer: Insights From Electronic Health Records and Natural Language Processing.解读早期及局部晚期非小细胞肺癌的复发情况:来自电子健康记录和自然语言处理的见解
JCO Clin Cancer Inform. 2025 Apr;9:e2400227. doi: 10.1200/CCI-24-00227. Epub 2025 Apr 18.
3
Diagnostic and Prognostic Value of hsa_piR_022710, hsa_piR_019822, and hsa_piR_020840 in Early-Stage Non-Small-Cell Lung Cancer: Implications for Recurrence and Survival in Squamous Cell Carcinoma Patients.hsa_piR_022710、hsa_piR_019822和hsa_piR_020840在早期非小细胞肺癌中的诊断和预后价值:对鳞状细胞癌患者复发和生存的意义
Int J Mol Sci. 2025 Mar 21;26(7):2870. doi: 10.3390/ijms26072870.
4
Prediction of Treatment Recommendations Via Ensemble Machine Learning Algorithms for Non-Small Cell Lung Cancer Patients in Personalized Medicine.通过集成机器学习算法对非小细胞肺癌患者进行个性化医疗中的治疗推荐预测。
Cancer Inform. 2024 Oct 14;23:11769351241272397. doi: 10.1177/11769351241272397. eCollection 2024.
5
Predictors of disease recurrence after radical resection and adjuvant chemotherapy in patients with stage IIb-IIIa squamous cell lung cancer: A retrospective analysis.IIb-IIIa期肺鳞状细胞癌患者根治性切除及辅助化疗后疾病复发的预测因素:一项回顾性分析
World J Exp Med. 2024 Mar 20;14(1):89319. doi: 10.5493/wjem.v14.i1.89319.
6
Comparison of deep learning-based recurrence-free survival with random survival forest and Cox proportional hazard models in Stage-I NSCLC patients.基于深度学习的无复发生存率与随机生存森林和Cox比例风险模型在I期非小细胞肺癌患者中的比较。
Cancer Med. 2023 Sep;12(18):19272-19278. doi: 10.1002/cam4.6479. Epub 2023 Aug 29.
7
Machine Learning-Assisted Recurrence Prediction for Patients With Early-Stage Non-Small-Cell Lung Cancer.机器学习辅助早期非小细胞肺癌患者的复发预测。
JCO Clin Cancer Inform. 2023 Jul;7:e2200062. doi: 10.1200/CCI.22.00062.
8
Clinical factors influencing long-term survival in a real-life cohort of early stage non-small-cell lung cancer patients in Spain.影响西班牙早期非小细胞肺癌患者真实队列长期生存的临床因素。
Front Oncol. 2023 Feb 23;13:1074337. doi: 10.3389/fonc.2023.1074337. eCollection 2023.
9
An Artificial Intelligence-Based Tool for Data Analysis and Prognosis in Cancer Patients: Results from the Clarify Study.一种基于人工智能的癌症患者数据分析与预后评估工具:Clarify研究结果
Cancers (Basel). 2022 Aug 22;14(16):4041. doi: 10.3390/cancers14164041.

本文引用的文献

1
Gender and lung cancer-SEER-based analysis.性别与肺癌——基于 SEER 的分析。
Ann Epidemiol. 2020 Jun;46:14-19. doi: 10.1016/j.annepidem.2020.04.003. Epub 2020 May 7.
2
Survival prediction model for non-small cell lung cancer based on somatic mutations.基于体细胞突变的非小细胞肺癌生存预测模型
J Gene Med. 2020 Sep;22(9):e3206. doi: 10.1002/jgm.3206. Epub 2020 Jun 11.
3
Overall survival prediction of non-small cell lung cancer by integrating microarray and clinical data with deep learning.利用深度学习整合微阵列和临床数据对非小细胞肺癌进行总体生存预测。
Sci Rep. 2020 Mar 13;10(1):4679. doi: 10.1038/s41598-020-61588-w.
4
DeepBTS: Prediction of Recurrence-free Survival of Non-small Cell Lung Cancer Using a Time-binned Deep Neural Network.DeepBTS:使用时间分箱深度神经网络预测非小细胞肺癌无复发生存率。
Sci Rep. 2020 Feb 6;10(1):1952. doi: 10.1038/s41598-020-58722-z.
5
Early survival prediction in non-small cell lung cancer from PET/CT images using an intra-tumor partitioning method.基于肿瘤内分区方法的 PET/CT 图像预测非小细胞肺癌早期生存率。
Phys Med. 2019 Apr;60:58-65. doi: 10.1016/j.ejmp.2019.03.024. Epub 2019 Mar 27.
6
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
7
Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy.ATG16L2 潜在功能变异预测非小细胞肺癌患者根治性放疗后放射性肺炎及结局
J Thorac Oncol. 2018 May;13(5):660-675. doi: 10.1016/j.jtho.2018.01.028. Epub 2018 Feb 15.
8
Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者肺癌的发病率及预测因素
ERJ Open Res. 2018 Feb 2;4(1). doi: 10.1183/23120541.00111-2016. eCollection 2018 Jan.
9
The effect of imputing missing clinical attribute values on training lung cancer survival prediction model performance.插补缺失临床属性值对训练肺癌生存预测模型性能的影响。
Health Inf Sci Syst. 2017 Dec 6;5(1):16. doi: 10.1007/s13755-017-0039-4. eCollection 2017 Dec.
10
Prediction of disease-free survival by the PET/CT radiomic signature in non-small cell lung cancer patients undergoing surgery.基于 PET/CT 影像组学特征预测行手术治疗的非小细胞肺癌患者的无病生存。
Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):207-217. doi: 10.1007/s00259-017-3837-7. Epub 2017 Sep 24.